Imeik Technology Development Co.,Ltd. (SHE: 300896)

Market Cap	50.63B
Revenue (ttm)	3.07B
Net Income (ttm)	2.03B
Shares Out	301.43M
EPS (ttm)	6.72
PE Ratio	25.01
Forward PE	22.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,853,339
Average Volume	2,248,397
Open	171.49
Previous Close	171.60
Day's Range	170.00 - 173.48
52-Week Range	132.81 - 282.72
Beta	1.38
RSI	30.04
Earnings Date	Mar 20, 2025

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 910
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2023, Imeik Technology Development Co.,Ltd.'s revenue was 2.87 billion, an increase of 47.99% compared to the previous year's 1.94 billion. Earnings were 1.86 billion, an increase of 47.08%.